iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Short Interest Report for September

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 218,618 shares, a growth of 847.2% from the September 15th total of 23,081 shares. Based on an average daily volume of 209,979 shares, the days-to-cover ratio is currently 1.0 days. Approximately 2.9% of the company’s stock are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. NewEdge Advisors LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 961 shares of the company’s stock, valued at approximately $32,000.

iShares Genomics Immunology and Healthcare ETF Stock Up 4.3%

Shares of IDNA stock traded up $1.75 during trading on Friday, reaching $42.17. The company’s stock had a trading volume of 151,574 shares, compared to its average volume of 67,732. The business has a fifty day moving average price of $38.99 and a 200-day moving average price of $33.57. The company has a market cap of $314.17 million, a price-to-earnings ratio of 14.76 and a beta of 0.94. iShares Genomics Immunology and Healthcare ETF has a one year low of $23.90 and a one year high of $43.44.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.